Literature DB >> 16955275

Short-term hyperthermia prevents activation of proinflammatory genes in fibroblast-like synoviocytes by blocking the activation of the transcription factor NF-kappaB.

Marica Markovic1, Karl M Stuhlmeier.   

Abstract

Fibroblast-like synoviocytes (FLS) play a key role in the genesis of rheumatoid arthritis (RA). FLS are among the most versatile cells with the potential to activate an array of genes that are able to initiate and propagate inflammation in RA-affected joints. Controlling activation of FLS might hold the key to restraining inflammation in RA-affected joints. In this study, we investigate the effect and mechanisms of short-term hyperthermia on a series of proinflammatory genes in FLS. In vitro experiments demonstrate that exposure of FLS to elevated temperatures for the duration of 30 min prevents activation of a series of genes with proinflammatory properties. Exposure to hyperthermia reduces IL-1beta-induced prostaglandin E2 release, suppresses activation of the adhesion molecules VCAM-1, ICAM-1, the cytokines TNFalpha, IL-1alpha, IL-1beta, IL-8 as well as COX-2 protein synthesis. Real time reverse transcriptase-polymerase chain reaction showed that hyperthermia altered gene expression at the transcriptional level. The amount and the duration of inhibition is gene-specific and lasts for up to 25 h. As to the mechanism of inhibition, electrophoretic mobility shift assay experiments demonstrated that exposure of FLS to hyperthermia prevents IL-1beta-induced NF-kappaB translocation and subsequent DNA binding. Many mechanisms have been shown to be involved in hyperthermia-mediated effects on NF-kappaB-DNA interactions. We demonstrate by Western blot experiments that in FLS, hyperthermia prevents the phosphorylation and subsequent degradation of IkappaBalpha, therefore retaining the NF-kappaB complex in the cytoplasm. Carefully controlled in vivo tests are certainly needed before one can take full advantage of those phenomena; however, the ease by which the temperature in joints can be modulated might offer an opportunity for manipulating inflammatory processes in joints by simple balneological means.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16955275     DOI: 10.1007/s00109-006-0089-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  45 in total

Review 1.  Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease.

Authors:  I J Benjamin; D R McMillan
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

2.  Major stress protein Hsp70 interacts with NF-kB regulatory complex in human T-lymphoma cells.

Authors:  I V Guzhova; Z A Darieva; A R Melo; B A Margulis
Journal:  Cell Stress Chaperones       Date:  1997-06       Impact factor: 3.667

3.  Heat shock proteins: new keys to the development of cytoprotective therapies.

Authors:  M Tytell; P L Hooper
Journal:  Expert Opin Ther Targets       Date:  2001-04       Impact factor: 6.902

4.  Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor.

Authors:  E Kalkhoven; S Wissink; P T van der Saag; B van der Burg
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

5.  Heat shock inhibits NF-kB activation in a dose- and time-dependent manner.

Authors:  Michael T Schell; Austin L Spitzer; Jennifer A Johnson; Diana Lee; Hobart W Harris
Journal:  J Surg Res       Date:  2005-08-31       Impact factor: 2.192

6.  Etiopathogenesis of rheumatoid arthritis-like disease in MRL/1 mice: II. Ultrastructural basis of joint destruction.

Authors:  A Tanaka; F X O'Sullivan; W J Koopman; S Gay
Journal:  J Rheumatol       Date:  1988-01       Impact factor: 4.666

7.  Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60.

Authors:  L M MacHt; C J Elson; J R Kirwan; J S Gaston; A G Lamont; J M Thompson; S J Thompson
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

8.  Gene transfer of heat-shock protein 70 reduces infarct size in vivo after ischemia/reperfusion in the rabbit heart.

Authors:  S Okubo; O Wildner; M R Shah; J C Chelliah; M L Hess; R C Kukreja
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

9.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.

Authors:  R I Scheinman; A Gualberto; C M Jewell; J A Cidlowski; A S Baldwin
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

Review 10.  Anti-inflammatory actions of the heme oxygenase-1 pathway.

Authors:  M J Alcaraz; P Fernández; M I Guillén
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  5 in total

1.  On Fever, famine, and war--but mostly fever.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2006-09-19       Impact factor: 4.599

2.  It is time to thoroughly study the effects of mild stress in rodents, but also in human beings.

Authors:  Eric Le Bourg
Journal:  Dose Response       Date:  2009-10-13       Impact factor: 2.658

3.  Expression of heat shock protein receptors on fibroblast-like synovial cells derived from rheumatoid arthritis-affected joints.

Authors:  Ilona Hromadnikova; Thi Thu Hien Nguyen; Denisa Zlacka; Lucie Sedlackova; Stanislav Popelka; David Veigl; Jan Pech; Pavla Vavrincova; Antonin Sosna
Journal:  Rheumatol Int       Date:  2008-01-30       Impact factor: 2.631

4.  Short Term Hyperthermia Prevents Activation of Proinflammatory Genes in Type B Synoviocytes by Blocking the Activation of the Transcription Factor NF-κB.

Authors:  Marica Markovic
Journal:  EJIFCC       Date:  2007-12-21

5.  Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis.

Authors:  You-Jung Ha; Sun-Mi Lee; Chin Hee Mun; Hyung Joon Kim; Yonghee Bae; Ji-Hee Lim; Kyu-Hyung Park; Soo-Kon Lee; Kyung-Hwa Yoo; Yong-Beom Park
Journal:  Arthritis Res Ther       Date:  2020-06-18       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.